Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04352426
Status:
COMPLETED
Last Update Posted:
2020-04-20
First Post:
2020-04-06
Brief Title:
Symptom-limited Stair Climbing Test in Heart Failure
Sponsor:
KTO Karatay University
Organization:
KTO Karatay University
Study Overview
Official Title:
Effectiveness of Symptom-limited Stair-climbing Test in the Determination of the Exercise Capacity of Patients With Chronic Heart Failure
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aims To assess the efficacy of symptom-limited stair-climbing test SLSCT in determining the exercise capacities of patients with chronic heart failure CHF in comparison with cardiopulmonary exercise test CPET and 6-minute walk test6MWT and to interpret the results according to the clinical status of the patients
Methods Thirty-one patients aged 50-75 years with stage II-III CHF according to the New York Heart Association Classification and left ventricular ejection fraction LVEF of 45 were included The demographic and clinical characteristics of the patients were recorded Exercise capacity was assessed by SLSCT 6MWT and CPET The duration of patients performance in the test reasons for ending the test and predicted maximal oxygen consumption VO2max were recorded Heart rate HR blood pressure BP dyspnoea severity Modified Borg Scale MBS and peripheral oxygen saturation were recorded Pulmonary functions were assessed by spirometry
Methods Thirty-one patients aged 50-75 years with stage II-III CHF according to the New York Heart Association Classification and left ventricular ejection fraction LVEF of 45 were included The demographic and clinical characteristics of the patients were recorded Exercise capacity was assessed by SLSCT 6MWT and CPET The duration of patients performance in the test reasons for ending the test and predicted maximal oxygen consumption VO2max were recorded Heart rate HR blood pressure BP dyspnoea severity Modified Borg Scale MBS and peripheral oxygen saturation were recorded Pulmonary functions were assessed by spirometry
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None